期刊文献+

原发性醛固酮增多症手术患者预后影响因素分析 被引量:1

Prognosis factors of patients with primary aldosteronism after adrenalectomy
原文传递
导出
摘要 目的分析原发性醛固酮增多症(pfimary aldosteronism,PA)患者术后血压恢复的影响因素。方法对2009年1月至2012年3月厦门大学附属第一医院泌尿中心收治的PA手术治疗患者进行回顾性研究及临床随访6个月~3年,将可能影响预后的因素进行单因素方差分析,初步筛选其中有统计学意义的指标,进一步采用logistic回归分析影响血压恢复的独立因素。结果93例PA术后患者中,根据影像及病理结果示:醛固酮腺瘤59例(63.44%),单侧肾上腺增生27例(29.03%),特发性醛固酮增多症7例(7.52%);术后血压恢复正常43例(46.24%),血压部分缓解47例(50.54%),血压无缓解3例(3.22%);采用logistic回归分析得出3个显著影响因素:高血压病史、术前降压药物控制血压情况、术前血浆醛固酮/肾素活性比值(aldosterone-to-renin ratio,ARR)。结论对于需手术的PA患者可根据其高血压病史、药物疗效及血浆ARR预判术后血压恢复情况,并加强术后随访及生活干预,提高综合治疗。 Objective To investigate the influential factors for recovery of blood pressure in patients with primary aldosteronism (PA)after adrenalectomy. Methods The clinical and follow up data(6-36 months)of patients with PA ,who underwent adrenalectomy between Jan. 2009 and Mar. 2012 were analyzed retrospectively. Factors which would be likely to influence prognosis were collected, and those which showed statistical significance by One-Way ANOVA analysis were screened, followed by further logistic regression analysis to obtain the independent factors related to outcome of these patients. Results Among the 93 PA patients after adrenalectomy, according to the imaging study and pathology results,59 patients were with adrenocortical adenomas (63.44%) ,27 patients with unilateral adrenal hyperplasia (29.03%) , and 7 patients with idiopathic hyperplasia (7.52%). 43 patients (46. 24% )returned to normal blood pressure after surgery, 47 patients (50. 54% )had blood pressure relief, and 3 patients (3.22%)had no improvement of blood pressure. Logistic regression analysis showed the influential factors were as following:history of hypertension, grade of hypertension after receiving medical treatment, and aldosterone renin ratio before surgery. Conclusions Recovery of blood pressure can be evaluated based on hypertension history, hypertension grade after receiving medical treatment, and aldosterone-to-renin ratio for patients needing adrenalectomy. In addition, the follow-up and life style intervention should be strengthened, and comprehensive treatment should be improved.
出处 《中华内分泌外科杂志》 CAS 2013年第6期478-482,共5页 Chinese Journal of Endocrine Surgery
基金 基金项目:国家自然科学基金项目(81200578,81100561) 福建省自然科学基金项目(2011D011)
关键词 原发性醛固酮增多症 血压 预后 LOGISTIC回归分析 Primary aldosteronism Blood pressure Prognosis Logistic regression analysis
  • 相关文献

参考文献27

  • 1Conn JW,Knopf RF,Nesbit RM. Clinical characteristics of primary aldosteronism from an analysis of 145 cases[J].{H}AMERICAN JOURNAL OF SURGERY,1992.159-172.
  • 2Gordon RD,Klemm SA,Tunny TJ. Primary aldosteronism:bypertension with a genetic basis[J].{H}LANCET,1992,(8812):159-161.
  • 3Rossi GP. Diagnosis and treatment of primary aldostemnism[J].{H}Endocrinology and Metabolism Clinics of North America,2011,(02):313-332.
  • 4Stowasser M,Gordon RD. Primary aldosteronism[J].{H}Best Practice and Research Clinical Endocrinology and Metablism,2003,(04):591-605.
  • 5Funder JW,Carey RM,Fardella C. Case detection,diagnosis,and treatment of patients with primary aldosteronism:an endocrine society clinical practice guideline[J].{H}Journal of Clinical Endocrinology and Metabolism,2008,(09):3266-3281.
  • 6Calhoun DA,Nishizaka MK,Zaman MA. Hyperaldosteronism among black and white subjects with resistant hypertension[J].{H}HYPERTENSION,2002,(06):892-896.
  • 7Douma S,Petidis K,Doumas M. Prevalence of primary hyperaldosteronism in resistant hypertension:a retrospective observational study[J].{H}LANCET,2008,(9628):1921-1926.
  • 8Schmiemann G,Gebhardt K,Hummers-Pmdier E. Prevalence of hyperaldostemnism in primary care patients with resistant hypertension[J].J Am Board Farm Med,2012,(01):98-103.
  • 9Milliez P,Girerd X,Plouin PF. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism[J].{H}Journal of the America College of Cardiology,2005,(08):1243-1248.
  • 10Born-Frontsberg E,Reincke M,Rump LC. Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldostemnism:results of the German Conn's Registry[J].{H}Journal of Clinical Endocrinology and Metabolism,2009,(04):1125-1130.

同被引文献19

  • 1Rossi GP, Bernini G, Caliumi C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients [J]. J Am Coil Cardiol, 2006,48 ( 11 ) : 2293-2300. DOI : 10. lO16/j, jacc. 2006.07. 059.
  • 2Calhoun DA, Nisbizaka MK, Zaman MA, et al. Hyperaldosteronism among black and white subjects with resistant hypertension [ J ]. Hypertension, 2002,40(6) :892-896.
  • 3Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline [ J ]. J Clin Endocrinol Metab, 2008,93 ( 9 ) : 3266-3281. DOI: 10. 1210/jc. 2008-0104.
  • 4Sang X, Jiang Y, Wang W, et al. Prevalence of and risk factors for primary aldosteronism among patients with resistant hypertension in China [J]. J Hypertens, 2013,31 (7) : 1465-1471 ; discussion 1471-1472. DOI: 10. 1097/HJH. ObO13e328360ddf6.
  • 5Fallo F, Veglio F, Bertello C, et al. Prevalence and eharaeteristics of the metabolic syndrome in primary aldosteronism [ J ]. J Clin Endocrinol Metal), 2006,91 (2) :454-459. DOI: 10. 1210/jc. 2005-1733.
  • 6Milliez P, Girerd X, Plouin PF, et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism [ J ]. J Am Coil Cardiol, 2005,45 ( 8 ) : 1243-1248. DOI : 10. 1016/j. jacc. 2005. 01.015.
  • 7Rossi GP, Seecia TM, Pessina AC. Primary aldosteronism: part I1: subtype differentiation and treatment [ J ]. J Nephrol, 2008,21 (4) :455- 462.
  • 8Rios MC, Izquierdo A, Solelo M, et al. Aldosterone/renin ratio in the diagnosis of primary. ',ddosteronism [ J ]. Medicina ( B Aires ) , 2011,71 (6) :525-530.
  • 9Rossi G, Boscaro M, Ronconi V, et al. Aldosterone as a cardiovascular risk factor[ J ]Trends Endocrinol Metab, 2005,16 ( 3 ) : 104-107. DOI : 10. 1016/j. tent. 2005.02. 010.
  • 10Reincke M, Rump LC, Quinkler M, et al. Risk factors associated with a low glomerular filtration rate inprimary aldosteronism [ J ]. J Clin Endocrinnl Metab, 2009,94 (3) :869-875. DOI: 10. 1210/je. 2008- 1851.

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部